A process is reported to obtain a nanoparticle sol from co-precipitated iron oxide particles without using any surfactant. The sol - a true ferrofluid - is not only stable over a wide range of pH but also in physiological solutions. This is a decisive step towards biomedical applications where nanoparticle agglomeration could so far only be prevented by using unwanted surfactants.

Introduction Therapeutic cell treatments have been applied to a large number of pathological diseases. Tracking the engraftment of cells is key to planning and assessing cell therapies. Migration dynamics and tissue integration are commonly assessed by locating iron-oxide labeled cells with T2* weighted MRI. Interpretation of the resulting signal voids can be challenging in preclinical scanners...

Pristine monocrystalline graphene is claimed to be the strongest material known with remarkable mechanical and electrical properties. However, graphene made with scalable fabrication techniques is polycrystalline and contains inherent nanoscale line and point defects--grain boundaries and grain-boundary triple junctions--that lead to significant statistical fluctuations in toughness and strengt...

O G Inorganic Nanoparticles for MRI Contrast Agents R E S By Hyon Bin Na, In Chan Song, and Taeghwan Hyeon* S R E P O R T Various inorganic nanoparticles have been used as magnetic resonance imaging (MRI) contrast agents due to their unique properties, such as large surface area and efficient contrasting effect. Since the first use of superparamagnetic iron oxide (SPIO) as a liver contrast agen...

introduction: iiron oxide nanoparticles (io np) have an increasing number of biomedical applications. to date, the potential cytotoxicity of these particles remains an issue of debate. little is known about the cellular interaction or toxic effects of io np on differentiation of stem cells. the aim of the present study was to investigate the possible toxic role of different doses of io np in di...

In this Letter, we report, for the first time, using polymer single crystal as magnetically recoverable support for nanoparticle catalysts. This catalyst system is composed of polymer single crystal, platinum nanoparticles, and iron oxide nanoparticles, which act as support, catalysts, and magnetic responsive materials, respectively. Platinum nanoparticles and iron oxide nanoparticles were bond...

We have developed a novel water-dispersible oleic acid (OA)-Pluronic-coated iron oxide magnetic nanoparticle formulation that can be loaded easily with high doses of water-insoluble anticancer agents. Drug partitions into the OA shell surrounding iron oxide nanoparticles, and the Pluronic that anchors at the OA-water interface confers aqueous dispersity to the formulation. Neither the formulati...

Nanoparticle drug carriers hold potential to improve current cancer therapy by delivering payload to the tumor environment and decreasing toxic side effects. Challenges in nanotechnology drug delivery include plasma instability, site-specific delivery, and relevant biomarkers. We have developed a triblock polymer comprising a hydroxamic acid functionalized center block that chelates iron to for...

Zero-valent iron nanoparticle technology is becoming an increasingly popular choice for treatment of hazardous and toxic wastes, and for remediation of contaminated sites. In the U.S. alone, more than 20 projects have been completed since 2001. More are planned or ongoing in North America, Europe, and Asia. The diminutive size of the iron nanoparticles helps to foster effective subsurface dispe...

In order to understand the role of plasma proteins in the rapid liver clearance of dextran-coated superparamagnetic iron oxide (SPIO) in vivo, we analyzed the full repertoire of SPIO-binding blood proteins using novel two-dimensional differential mass spectrometry approach. The identified proteins showed specificity for surface domains of the nanoparticles: mannan-binding lectins bound to the d...